Search

everythinglearnresearchcommunity

for

Search:↓

Leflunomide and methotrexate are similarly effective for rheumatoid arthritis but have different side effects.

Rosemary and kalonji seeds can improve hair health and treat hair conditions.

Alopecia in patients with epidermolysis bullosa varies in severity and is often caused by skin blistering or trauma.

Orphan drug benefit scores in Germany are influenced by phase III data and lack of alternatives, but not linked to price or discounts.

Multi-pass laser skin treatments improved healing, reduced pain, and had no major complications.

Managing metabolic syndrome needs both lifestyle changes and medical treatments.

Polycystic ovary syndrome affects about 6-10% of women, with varying symptoms and the need for standardized global definitions.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

Mostly postmenopausal Caucasian women get Frontal Fibrosing Alopecia, which often includes eyebrow loss and has limited treatment success.

Alopecia areata significantly lowers the quality of life, especially in emotional and mental health aspects.

No effective treatment for frontal fibrosing alopecia was found, but oral 5-alpha-reductase inhibitors had the best response; for lichen planopilaris, topical corticosteroids were commonly used but had a high relapse rate.

JAK inhibitors help with skin conditions but need more research on dosing and safety.

Lower SHBG levels may increase the risk of PCOS.

Tofacitinib is somewhat effective for alopecia areata, but more research is needed on its safety and long-term effects.

Dupilumab is being tested for many new skin, respiratory, and gastrointestinal conditions.

Certain gene variants may contribute to high androgen levels in women with polycystic ovary syndrome.

JAK inhibitors show promise for treating skin and hair disorders but need more research on long-term safety and effectiveness.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Platelet-rich plasma treatment for non-scarring hair loss shows mixed results and needs more research.

The document concludes that eyelash trichomegaly, which is the abnormal growth of eyelashes, can be present from birth, caused by diseases, or result from certain medications.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Chromium supplements don't improve insulin, hormone levels, or cholesterol in women with PCOS but raise testosterone levels.

People undergoing chemotherapy need better support and information to cope with hair loss.

Visible light can improve skin disorders and hair loss, but more research is needed to understand long-term effects.

Combination therapies work better than single treatments for hair loss.

Low-level laser therapy safely and effectively improves hair growth and coverage for male and female pattern hair loss.

Patients with PCOS tend to score their hirsutism higher than clinicians, making self-scoring less useful for diagnosis.

Most patients with frontal fibrosing alopecia are middle-aged women, often have thyroid disease, and some treatments can help stabilize the condition.

AI is effective in diagnosing and treating hair disorders, including detecting hair loss and scalp conditions with high accuracy, but it should supplement, not replace, doctor-patient interactions.

Taking 5-alpha reductase inhibitors does not increase the risk of breast cancer in men.